Hedge Fund - Commodore Capital
Enliven Therapeutics Inc ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q2 (2025-06-30) | $94,137,749 | 6.64% | 4,692,809 | $ |
| 2 | 2025 - Q1 (2025-03-31) | $92,004,000 | 6.78% | 4,675,000 | $ |
| 3 | 2024 - Q4 (2024-12-31) | $94,612,500 | 6.93% | 4,205,000 | $ |
| 4 | 2024 - Q3 (2024-09-30) | $104,714,000 | 6.54% | 4,100,000 | $ |
| 5 | 2024 - Q2 (2024-06-30) | $92,854,736 | 6.33% | 3,973,245 | $ |
| 6 | 2024 - Q1 (2024-03-31) | $69,889,380 | 4.67% | 3,973,245 | $ |
| 7 | 2023 - Q4 (2023-12-31) | $40,161,133 | 3.5% | 2,901,816 | $ |
| 8 | 2023 - Q3 (2023-09-30) | $39,638,807 | 4.63% | 2,901,816 | $ |
| 9 | 2023 - Q2 (2023-06-30) | $47,928,232 | 5.38% | 2,348,272 | $ |
| 10 | 2023 - Q1 (2023-03-31) | $37,916,894 | 5.77% | 1,731,365 | $ |
The displayed share prices are average quarterly stock market prices.